Cargando…

Delivering Monoclonal Antibody Infusions to Novel Outpatient Settings

Geisinger administered monoclonal antibody infusions to patients with Covid-19 at a range of treatment locations, including residential care facilities and a prison.

Detalles Bibliográficos
Autores principales:	Minnich, Amy, Rocha, Daniel, Hu, Yirui, Boell, Keith, Burke, Greg F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245317/ http://dx.doi.org/10.1056/CAT.21.0463

Ejemplares similares

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients
por: Piccicacco, Nicholas, et al.
Publicado: (2021)

Clinical development methodology for infusion-related reactions with monoclonal antibodies
por: Doessegger, Lucette, et al.
Publicado: (2015)

The importance of early identification of infusion-related reactions to monoclonal antibodies
por: Cáceres, Macarena C, et al.
Publicado: (2019)

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model
por: Razonable, Raymund R., et al.
Publicado: (2021)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
por: Saengsirinavin, Aim-on, et al.
Publicado: (2021)

Monoclonal Antibody Infusion Service for Obstetric Women Infected With COVID-19
por: Hiner, Jacqueline B., et al.
Publicado: (2022)

Acute low back pain as infusion-related reaction to monoclonal antibodies
por: Majenka, Pawel, et al.
Publicado: (2023)

HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting
por: Devine, F., et al.
Publicado: (2023)

Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting
por: Jones, Bruce M, et al.
Publicado: (2020)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
por: Varo, Amalia, et al.
Publicado: (2023)

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
por: Song, Xue, et al.
Publicado: (2011)

Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
por: Morgan, Kelsey Woods, et al.
Publicado: (2021)

More Accessible COVID-19 Treatment Through Monoclonal Antibody Infusion in the Emergency Department
por: Heinert, Sara W., et al.
Publicado: (2022)

Standing-up COVID-19 monoclonal antibody infusion centers: Infection prevention and control
por: Brewer, Brooke, et al.
Publicado: (2023)

Feasibility and impact of a monoclonal antibody infusion program in reaching vulnerable underserved communities
por: Mena Lora, Alfredo J., et al.
Publicado: (2023)

532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities
por: Hare, Allison J, et al.
Publicado: (2021)

Novel monoclonal antibodies to study tissue regeneration in planarians
por: Ross, Kelly G, et al.
Publicado: (2015)

Anti-PrP(C )monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
por: Chung, Erika, et al.
Publicado: (2010)

Monoclonal antibody infusion for COVID-19 infection: results from a tertiary referral center
por: Voelker, Dayne, et al.
Publicado: (2022)

The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
por: Sakata, Theadora, et al.
Publicado: (2021)

Generation and diversification of recombinant monoclonal antibodies
por: DeLuca, Keith F, et al.
Publicado: (2021)

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
por: Wynia, Matthew K., et al.
Publicado: (2023)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA
por: Borrajo, Mireya L., et al.
Publicado: (2021)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Goldin, Laurel, et al.
Publicado: (2021)

Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings
por: Germovsek, Eva, et al.
Publicado: (2021)

Outpatient Management of COVID-19 With Monoclonal Antibody Therapy in a Young Renal Transplant Patient
por: Malik, Bilal, et al.
Publicado: (2021)

Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19
por: Ruggeri, Matteo, et al.
Publicado: (2023)

MPET(2): a multi-network poroelastic and transport theory for predicting absorption of monoclonal antibodies delivered by subcutaneous injection
por: Wang, Hao, et al.
Publicado: (2023)

Virtual consultations: delivering outpatient clinics in paediatric surgery during the COVID-19 pandemic
por: Charnell, A. M., et al.
Publicado: (2020)

A systematic review of substance use screening in outpatient behavioral health settings
por: Woodward, Diana, et al.
Publicado: (2023)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H
por: Fülöp, Tamás, et al.
Publicado: (2018)

Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment
por: Woltemate, Thomas J., et al.
Publicado: (2021)

537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center
por: Patel, Pratish C, et al.
Publicado: (2021)

Improvement of Cyclic Vomiting Syndrome with Outpatient Ketamine Infusions
por: Carpenter, Anna, et al.
Publicado: (2021)

Uptake of Outpatient Monoclonal Antibody Treatments for COVID-19 in the United States: a Cross-Sectional Analysis
por: Anderson, Timothy S., et al.
Publicado: (2021)

Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives
por: Hamer, Mika K., et al.
Publicado: (2022)

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
por: Douin, David J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ofqlfrvdrr1hruco3iceit1hog